Genocea Biosciences, Inc. GNCA
Set alert
0.00 0.00 0.00%
As of Dec 22, 2:54 PM ET
0.0001 Day range 0.0001
52-week range unavailable
- Open
- 0.0007
- Prev close
- 0.0001
- Mkt cap
- 0
- Vol
- 30.27K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0001
- High
- 0.0001
- Forward P/E
- -0.02
- Beta
- 1.95
- Short ratio
- 0.74
- Inst. own
- 40.93%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 29, 2022
- 50-d avg
- 0.134553
- 200-d avg
- 0.978319
- 1y target
- 3.08
6M chart
Events in this range
- Jun 30, 2022Earnings: —; estimate -0.16; surprise —%
Signals (20)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Dec 8, 2022 | 3 years ago |
| SMA: Bearish | Dec 1, 2022 | 3 years ago |
| SMA: Bullish | Nov 29, 2022 | 3 years ago |
| MACD: Buy Signal | Nov 29, 2022 | 3 years ago |
| MACD: Sell Signal | Nov 28, 2022 | 3 years ago |
| SMA: Bearish | Nov 25, 2022 | 3 years ago |
| SMA: Bearish | Nov 25, 2022 | 3 years ago |
| SMA: Bullish | Nov 23, 2022 | 3 years ago |
| SMA: Bullish | Nov 18, 2022 | 3 years ago |
| MACD: Buy Signal | Nov 16, 2022 | 3 years ago |
| MACD: Sell Signal | Nov 15, 2022 | 3 years ago |
| MACD: Buy Signal | Nov 10, 2022 | 3 years ago |
| MACD: Sell Signal | Nov 7, 2022 | 3 years ago |
| MACD: Buy Signal | Oct 26, 2022 | 4 years ago |
| RSI: Oversold | Oct 14, 2022 | 4 years ago |
| MACD: Sell Signal | Oct 4, 2022 | 4 years ago |
| SMA: Bearish | Oct 3, 2022 | 4 years ago |
| SMA: Bullish | Sep 21, 2022 | 4 years ago |
| RSI: Oversold | Aug 16, 2022 | 4 years ago |
| RSI: Oversold | Aug 9, 2022 | 4 years ago |
Valuation
P/E -5.3×
FY 2012 5y median -1.1× FY 2021
P/S 48.5×
FY 2012 5y median 0.0× FY 2021
P/B 2.9×
FY 2012 5y median 2.9× FY 2021
P/FCF -1.6×
FY 2012 5y median -1.1× FY 2021
EV/EBITDA -3.2×
FY 2012 5y median -0.7× FY 2021
EV/Sales 32.6×
FY 2012 5y median 0.0× FY 2021
FCF Yield -61.2%
FY 2012 5y median -91.0% FY 2021
Profitability
Gross Margin 100.0%
FY 2012 5y median 0.0% FY 2021
Operating Margin -3174.5%
FY 2012 5y median 0.0% FY 2021
Net Margin -939.7%
FY 2012 5y median 0.0% FY 2021
ROE -57.0%
FY 2012 5y median -155.5% FY 2021
ROIC -54.7%
FY 2012 5y median -82.2% FY 2021
ROA -27.6%
FY 2012 5y median -74.0% FY 2021
Growth (YoY)
Revenue 20.8%
FY 2012 FY 2021
Operating Income -10.9%
FY 2012 FY 2021
EPS (diluted) 64.5%
FY 2012 FY 2021
Free Cash Flow -10.0%
FY 2012 FY 2021
Financial Health
Current Ratio 2.2×
FY 2012 5y median 2.5× FY 2021
Quick Ratio 2.2×
FY 2012 5y median 2.5× FY 2021
Debt / Equity 0.4×
FY 2012 5y median 0.6× FY 2021
Net Debt / EBITDA 1.6×
FY 2012 5y median 0.7× FY 2021
Interest Coverage 46.5×
FY 2012 5y median -34.0× FY 2021
Dividends
Dividend Yield 0.0%
FY 2012 5y median 0.0% FY 2021
Payout Ratio 0.0%
FY 2012 5y median 0.0% FY 2021
Annual · latest fiscal year ends 2021-12-31
